New trial data show aflibercept 8 mg and faricimab extend dosing to 16–20 weeks in AMD, DME, RVO while maintaining safety.

For patients with diabetic macular edema (DME), intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Please provide your email address to receive an email when new articles are posted on . Wet AMD developed in 2.03% of eyes after an average of two injections. There was one case of vitreous hemorrhage ...

Sustained-release intraocular implants represent a rapidly advancing class of ophthalmic drug-delivery platforms engineered to maintain therapeutic intraocular concentrations over months to years. By ...

NEWTON, Mass.--(BUSINESS WIRE)--#NRTIs--Inflammasome Therapeutics, a private, clinical-stage biotech company developing novel, first-in-class, dual inflammasome inhibitors for prevalent ophthalmic and ...

ABSTRACT: Introduction: Cortisone glaucoma is a secondary glaucoma iatrogenic open angle induced by corticosteroids administered locally or systemically for chronic conditions, most often inflammatory ...

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (https://www.inflam.com), is a clinical-stage biotech company developing a new class of inflammasome inhibitors called Kamuvudines for ...

The retrospective study analyzed the clinical data of 40 patients (40 eyes) with BRVO-induced macular edema between March 2020 and March 2023. All patients received intravitreal injections of ...